These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 38773707

  • 1. Platelet hyperresponsiveness and increased platelet-neutrophil aggregates in dogs with myxomatous mitral valve disease and pulmonary hypertension.
    Duler L, Visser L, Nguyen N, Johnson LR, Stern JA, Li RHL.
    J Vet Intern Med; 2024; 38(4):2052-2063. PubMed ID: 38773707
    [Abstract] [Full Text] [Related]

  • 2. Serotonin concentrations in platelets, plasma, mitral valve leaflet, and left ventricular myocardial tissue in dogs with myxomatous mitral valve disease.
    Cremer SE, Singletary GE, Olsen LH, Wallace K, Häggström J, Ljungvall I, Höglund K, Reynolds CA, Pizzinat N, Oyama MA.
    J Vet Intern Med; 2014; 28(5):1534-40. PubMed ID: 25146933
    [Abstract] [Full Text] [Related]

  • 3. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
    Cremer SE, Kristensen AT, Reimann MJ, Eriksen NB, Petersen SF, Marschner CB, Tarnow I, Oyama MA, Olsen LH.
    Am J Vet Res; 2015 Jun; 76(6):520-31. PubMed ID: 26000599
    [Abstract] [Full Text] [Related]

  • 4. Plasma and platelet serotonin concentrations in healthy dogs and dogs with myxomatous mitral valve disease.
    Mangklabruks T, Surachetpong SD.
    J Vet Cardiol; 2014 Sep; 16(3):155-62. PubMed ID: 25127665
    [Abstract] [Full Text] [Related]

  • 5. Myxomatous mitral valve disease and associated pulmonary hypertension might increase serum angiopoietin-2 in dogs.
    Yu H, Lee D, Chae Y, Choi M, Lee Y, Yun T, Kang BT, Yang MP, Kim H.
    Am J Vet Res; 2024 Jun 01; 85(6):. PubMed ID: 38531156
    [Abstract] [Full Text] [Related]

  • 6. The prevalence of pulmonary hypertension in Cavalier King Charles spaniels compared with other breeds with myxomatous mitral valve disease.
    Sudunagunta S, Green D, Christley R, Dukes-McEwan J.
    J Vet Cardiol; 2019 Jun 01; 23():21-31. PubMed ID: 31174726
    [Abstract] [Full Text] [Related]

  • 7. Serum serotonin concentration is associated with severity of myxomatous mitral valve disease in dogs.
    Ljungvall I, Höglund K, Lilliehöök I, Oyama MA, Tidholm A, Tvedten H, Häggström J.
    J Vet Intern Med; 2013 Jun 01; 27(5):1105-12. PubMed ID: 23865457
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of pulmonary vascular resistance estimated by echocardiography in dogs with myxomatous mitral valve disease and pulmonary hypertension.
    Yuchi Y, Suzuki R, Yasumura Y, Saito T, Teshima T, Matsumoto H, Koyama H.
    J Vet Intern Med; 2023 Jun 01; 37(3):856-865. PubMed ID: 36994902
    [Abstract] [Full Text] [Related]

  • 9. Differentially expressed platelet activation-related genes in dogs with stage B2 myxomatous mitral valve disease.
    Zhou Q, Cui X, Zhou H, Guo S, Wu Z, Li L, Zhang J, Feng W, Guo Y, Ma X, Chen Y, Qiu C, Xu M, Deng G.
    BMC Vet Res; 2023 Dec 13; 19(1):271. PubMed ID: 38087280
    [Abstract] [Full Text] [Related]

  • 10. Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    Valente C, Guglielmini C, Domenech O, Contiero B, Zini E, Poser H.
    PLoS One; 2020 Dec 13; 15(9):e0238440. PubMed ID: 32870923
    [Abstract] [Full Text] [Related]

  • 11. Tricuspid annular plane systolic excursion in dogs with myxomatous mitral valve disease with and without pulmonary hypertension.
    Poser H, Berlanda M, Monacolli M, Contiero B, Coltro A, Guglielmini C.
    J Vet Cardiol; 2017 Jun 13; 19(3):228-239. PubMed ID: 28579307
    [Abstract] [Full Text] [Related]

  • 12. Plasma humanin as a prognostic biomarker for canine myxomatous mitral valve disease: a comparison with plasma NT-roBNP.
    Mangkhang K, Punyapornwithaya V, Tankaew P, Pongkan W, Chattipakorn N, Boonyapakorn C.
    Pol J Vet Sci; 2018 Dec 13; 21(4):673-680. PubMed ID: 30605282
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease.
    Ljungvall I, Rajamäki MM, Crosara S, Olsen LH, Kvart C, Borgarelli M, Höglund K, Häggström J.
    Am J Vet Res; 2011 Aug 13; 72(8):1022-8. PubMed ID: 21801058
    [Abstract] [Full Text] [Related]

  • 14. Hemostatic function in Cavalier King Charles Spaniels assessed using thromboelastography.
    Öberg J, Lilliehöök I, Höglund K, Ljungvall I.
    Vet Clin Pathol; 2019 Dec 13; 48(4):636-644. PubMed ID: 31650577
    [Abstract] [Full Text] [Related]

  • 15. Perivascular inflammatory cells and their association with pulmonary arterial remodelling in dogs with pulmonary hypertension due to myxomatous mitral valve disease.
    Sakarin S, Rungsipipat A, Surachetpong SD.
    Vet Res Commun; 2023 Sep 13; 47(3):1505-1521. PubMed ID: 36976445
    [Abstract] [Full Text] [Related]

  • 16. Iron parameters analysis in dogs with myxomatous mitral valve disease.
    Kumiega E, A Kobak K, Noszczyk-Nowak A, Kasztura M.
    BMC Vet Res; 2024 May 18; 20(1):210. PubMed ID: 38762716
    [Abstract] [Full Text] [Related]

  • 17. Right ventricular outflow tract fractional shortening: an echocardiographic index of right ventricular systolic function in dogs with pulmonary hypertension.
    Caivano D, Rishniw M, Birettoni F, Patata V, Giorgi ME, Dei K, Porciello F.
    J Vet Cardiol; 2018 Oct 18; 20(5):354-363. PubMed ID: 30145181
    [Abstract] [Full Text] [Related]

  • 18. Two-dimensional echocardiographic estimates of left atrial function in healthy dogs and dogs with myxomatous mitral valve disease.
    Dickson D, Caivano D, Matos JN, Summerfield N, Rishniw M.
    J Vet Cardiol; 2017 Dec 18; 19(6):469-479. PubMed ID: 29111284
    [Abstract] [Full Text] [Related]

  • 19. Utility of Tissue Doppler Imaging in the Echocardiographic Evaluation of Left and Right Ventricular Function in Dogs with Myxomatous Mitral Valve Disease with or without Pulmonary Hypertension.
    Baron Toaldo M, Poser H, Menciotti G, Battaia S, Contiero B, Cipone M, Diana A, Mazzotta E, Guglielmini C.
    J Vet Intern Med; 2016 May 18; 30(3):697-705. PubMed ID: 27177623
    [Abstract] [Full Text] [Related]

  • 20. Investigation of red blood cell and platelet indices in adult dogs suffered from myxomatous mitral valve disease with and without pulmonary hypertension.
    Tangmahakul N, Orton EC, Surachetpong SD.
    Front Vet Sci; 2023 May 18; 10():1234768. PubMed ID: 37781288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.